Logo image of ALFLO.PA

FLORENTAISE SA (ALFLO.PA) Stock Fundamental Analysis

EPA:ALFLO - Euronext Paris - Matif - FR001400GO75 - Common Stock - Currency: EUR

0.962  +0.06 (+6.89%)

Fundamental Rating

1

ALFLO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. ALFLO may be in some trouble as it scores bad on both profitability and health. ALFLO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALFLO has reported negative net income.
ALFLO had a negative operating cash flow in the past year.
Of the past 5 years ALFLO 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ALFLO reported negative operating cash flow in multiple years.
ALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFALFLO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M 4M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.21%, ALFLO is doing worse than 60.00% of the companies in the same industry.
ALFLO's Return On Equity of -0.68% is on the low side compared to the rest of the industry. ALFLO is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROIC N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALFLO.PA Yearly ROA, ROE, ROICALFLO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of ALFLO has declined.
ALFLO has a better Gross Margin (47.58%) than 66.15% of its industry peers.
In the last couple of years the Gross Margin of ALFLO has declined.
ALFLO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5YN/A
ALFLO.PA Yearly Profit, Operating, Gross MarginsALFLO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

1

2. Health

2.1 Basic Checks

ALFLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALFLO has about the same amout of shares outstanding than it did 1 year ago.
ALFLO has a better debt/assets ratio than last year.
ALFLO.PA Yearly Shares OutstandingALFLO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALFLO.PA Yearly Total Debt VS Total AssetsALFLO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

ALFLO has an Altman-Z score of 0.52. This is a bad value and indicates that ALFLO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.52, ALFLO is doing worse than 83.08% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that ALFLO is somewhat dependend on debt financing.
ALFLO has a Debt to Equity ratio of 0.59. This is in the lower half of the industry: ALFLO underperforms 66.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 0.52
ROIC/WACCN/A
WACC5.45%
ALFLO.PA Yearly LT Debt VS Equity VS FCFALFLO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.58 indicates that ALFLO may have some problems paying its short term obligations.
The Current ratio of ALFLO (0.58) is worse than 93.85% of its industry peers.
A Quick Ratio of 0.23 indicates that ALFLO may have some problems paying its short term obligations.
ALFLO has a worse Quick ratio (0.23) than 96.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.23
ALFLO.PA Yearly Current Assets VS Current LiabilitesALFLO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALFLO have decreased strongly by -79.41% in the last year.
Looking at the last year, ALFLO shows a very negative growth in Revenue. The Revenue has decreased by -13.68% in the last year.
The Revenue has been growing slightly by 7.20% on average over the past years.
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.1%
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALFLO.PA Yearly Revenue VS EstimatesALFLO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFLO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALFLO.PA Price Earnings VS Forward Price EarningsALFLO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALFLO is valued a bit cheaper than 64.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.16
ALFLO.PA Per share dataALFLO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALFLO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FLORENTAISE SA

EPA:ALFLO (6/5/2025, 7:00:00 PM)

0.962

+0.06 (+6.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners92.45%
Ins Owner ChangeN/A
Market Cap7.94M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP10.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB N/A
EV/EBITDA 9.16
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS7.06
BVpS3.7
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.21%
ROE -0.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.58%
FCFM N/A
ROA(3y)2.81%
ROA(5y)N/A
ROE(3y)13.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.21%
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5YN/A
F-Score2
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA 3.22
Cap/Depr 128.95%
Cap/Sales 14.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.23
Altman-Z 0.52
F-Score2
WACC5.45%
ROIC/WACCN/A
Cap/Depr(3y)183.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.41%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%-54.1%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y7.2%
Revenue growth 5YN/A
Sales Q2Q%31.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.41%
OCF growth 3YN/A
OCF growth 5YN/A